Compass points to positive psilocybin trial, but shares fallCompass Pathways has reported that its drug for treatment-resistant depression (TRD) based on magic mushroom ingredient psilocybin was Share XCompass points to positive psilocybin trial, but shares fallhttps://pharmaphorum.com/news/compass-points-to-positive-psilocybin-trial-but-shares-fall/
Psychedelics startup Beckley attracts Janssen neuroscience VPPsychedelic medicines specialist Beckley Psytech has enticed a senior figure in Janssen’s neuroscience division to take on the Share XPsychedelics startup Beckley attracts Janssen neuroscience VPhttps://pharmaphorum.com/news/psychedelics-startup-beckley-attracts-janssen-neuroscience-vp/
First subject dosed in psilocybin trial for rare headache disorderThe first patient has received a low dose of Beckley Psytech’s psychedelic medicine psilocybin in a clinical trial Share XFirst subject dosed in psilocybin trial for rare headache disorderhttps://pharmaphorum.com/news/first-subject-dosed-in-psilocybin-trial-for-rare-headache-disorder/
Beckley Psytech raises $80m for psychedelic meds developmentUK psychedelic medicine specialist Beckley Psytech has raised an impressive £58 million (around $80 million) in an oversubscribed Share XBeckley Psytech raises $80m for psychedelic meds developmenthttps://pharmaphorum.com/news/beckley-psytech-raises-80m-for-psychedelic-meds-development/
MDMA on track for 2023 approval as PTSD therapy, says developerA medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp Share XMDMA on track for 2023 approval as PTSD therapy, says developerhttps://pharmaphorum.com/news/mdma-on-track-for-2023-approval-as-ptsd-therapy-says-developer/
Magic mushroom compound matches antidepressant in clinical trialThe active compound in magic mushrooms – psilocybin – seems to be at least as effective as a Share XMagic mushroom compound matches antidepressant in clinical trialhttps://pharmaphorum.com/news/magic-mushroom-compound-matches-antidepressant-in-clinical-trial/
VC fund dedicated to psychedelic meds launches in UKIn the last few years, biopharma companies focusing on psychedelic medicines have been springing up like mushrooms – Share XVC fund dedicated to psychedelic meds launches in UKhttps://pharmaphorum.com/news/vc-fund-dedicated-to-psychedelic-meds-launches-in-uk/
Field Trip becomes latest psychedelic firm to go publicPsychedelic therapy company Field Trip Psychedelics has announced that it will soon join the growing list of psychedelic Share XField Trip becomes latest psychedelic firm to go publichttps://pharmaphorum.com/news/field-trip-becomes-latest-psychedelic-firm-to-go-public/
